What is the management for a patient with hyponatremia and a serum sodium level of 123 mmol/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyponatremia with Serum Sodium Level of 123 mmol/L

For a patient with hyponatremia and serum sodium of 123 mmol/L, stop diuretics if present, assess volume status, and if the patient has normal renal function with no severe symptoms, implement fluid restriction (1-1.5 L/day) while avoiding rapid correction exceeding 8 mmol/L in 24 hours.

Initial Assessment and Classification

First, determine the volume status of the patient, which is crucial for appropriate management:

  • Hypovolemic: Look for signs of orthostatic hypotension, dry mucous membranes, tachycardia, and urine sodium <20 mEq/L
  • Euvolemic: Normal vital signs, no edema, urine sodium >20-40 mEq/L
  • Hypervolemic: Edema, ascites, elevated JVP, urine sodium <20 mEq/L 1

Management Algorithm Based on Volume Status

1. Hypovolemic Hyponatremia (e.g., from diuretic use, GI losses)

  • Immediately discontinue diuretics if applicable 2
  • Administer isotonic saline for volume expansion 2
  • Monitor serum sodium every 4 hours initially to avoid overly rapid correction 1

2. Euvolemic Hyponatremia (e.g., SIADH)

  • Fluid restriction (1-1.5 L/day) 2, 1
  • Consider tolvaptan for persistent hyponatremia, but only in a hospital setting where sodium can be closely monitored 3
    • Starting dose: 15 mg once daily
    • May increase to 30 mg after 24 hours if needed
    • Maximum dose: 60 mg daily
    • Do not administer for more than 30 days due to risk of liver injury 3

3. Hypervolemic Hyponatremia (e.g., cirrhosis, heart failure)

  • For serum sodium 121-125 mmol/L with normal renal function:
    • Some experts recommend continuing diuretics, while others suggest stopping diuretics and adopting a more cautious approach 2
    • Fluid restriction (1-1.5 L/day) 2
  • For serum sodium 121-125 mmol/L with elevated creatinine (>150 mmol/L or >120 mmol/L and rising):
    • Stop diuretics and give volume expansion with colloid or saline 2

Correction Rate Considerations

  • Maximum correction rate: Do not exceed 8 mmol/L in 24 hours 2, 1
  • For severe symptomatic hyponatremia (seizures, coma, severe neurological symptoms):
    • Use 3% hypertonic saline to increase serum sodium by 4-6 mmol/L within 1-2 hours 1, 4
    • Then slow the correction rate to avoid osmotic demyelination syndrome 1

Special Considerations for Cirrhotic Patients

For patients with cirrhosis and hyponatremia:

  • Avoid water restriction in patients with uncomplicated ascites 2
  • For serum sodium 121-125 mmol/L: Consider stopping diuretics and observe the patient 2
  • For serum sodium <120 mmol/L: Stop diuretics and consider volume expansion with colloid or saline 2

Monitoring During Treatment

  • Frequent monitoring of serum sodium levels (every 2-4 hours initially) 1
  • Assess volume status regularly during treatment 1
  • Watch for signs of overly rapid correction, which can lead to osmotic demyelination syndrome 3

Pitfalls and Caveats

  1. Avoid overly rapid correction (>8 mmol/L in 24 hours) which can cause osmotic demyelination syndrome, resulting in dysarthria, mutism, dysphagia, seizures, or death 3, 4

  2. Water restriction alone is often ineffective in significantly improving sodium levels but can prevent further deterioration 2

  3. Tolvaptan should only be initiated in a hospital setting where serum sodium can be closely monitored 3

  4. Avoid using tolvaptan in patients with autosomal dominant polycystic kidney disease due to risk of hepatotoxicity 3

  5. Patients with chronic hyponatremia (>48 hours) require slower correction rates than those with acute hyponatremia 1, 5

  6. Hyponatremia in cirrhotic patients requires special consideration as water restriction may exacerbate central hypovolemia and worsen ADH secretion 2

References

Guideline

Cerebral Salt Wasting and SIADH Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The treatment of severe hyponatremia.

Kidney international. Supplement, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.